BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18353697)

  • 1. Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.
    Martin DR; Rigat BA; Foureman P; Varadarajan GS; Hwang M; Krum BK; Smith BF; Callahan JW; Mahuran DJ; Baker HJ
    Mol Genet Metab; 2008 Jun; 94(2):212-21. PubMed ID: 18353697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Bangladeshi domestic cats with GM1 gangliosidosis caused by the c.1448G>C mutation of the feline GLB1 gene: case study.
    Uddin MM; Hossain MA; Rahman MM; Chowdhury MA; Tanimoto T; Yabuki A; Mizukami K; Chang HS; Yamato O
    J Vet Med Sci; 2013; 75(3):395-7. PubMed ID: 23123943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization.
    Muthupalani S; Torres PA; Wang BC; Zeng BJ; Eaton S; Erdelyi I; Ducore R; Maganti R; Keating J; Perry BJ; Tseng FS; Waliszewski N; Pokras M; Causey R; Seger R; March P; Tidwell A; Pfannl R; Seyfried T; Kolodny EH; Alroy J
    Mol Genet Metab; 2014 Apr; 111(4):513-21. PubMed ID: 24581871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.
    Samoylova TI; Martin DR; Morrison NE; Hwang M; Cochran AM; Samoylov AM; Baker HJ; Cox NR
    Metab Brain Dis; 2008 Jun; 23(2):161-73. PubMed ID: 18421424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of GM1 gangliosidosis in a Siamese cat from Japan in the 1960s.
    Uddin MM; Tanimoto T; Yabuki A; Kotani T; Kuwamura M; Chang HS; Yamato O
    J Feline Med Surg; 2012 Dec; 14(12):900-2. PubMed ID: 22772479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis.
    Gross AL; Gray-Edwards HL; Bebout CN; Ta NL; Nielsen K; Brunson BL; Lopez Mercado KR; Osterhoudt DE; Batista AR; Maitland S; Seyfried TN; Sena-Esteves M; Martin DR
    Brain; 2022 Apr; 145(2):655-669. PubMed ID: 34410345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
    Hinek A; Zhang S; Smith AC; Callahan JW
    Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis.
    Kreutzer R; Kreutzer M; Pröpsting MJ; Sewell AC; Leeb T; Naim HY; Baumgärtner W
    J Cell Mol Med; 2008; 12(5A):1661-71. PubMed ID: 18088383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis.
    Caciotti A; Donati MA; Boneh A; d'Azzo A; Federico A; Parini R; Antuzzi D; Bardelli T; Nosi D; Kimonis V; Zammarchi E; Morrone A
    Hum Mutat; 2005 Mar; 25(3):285-92. PubMed ID: 15714521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.
    Caciotti A; Donati MA; d'Azzo A; Salvioli R; Guerrini R; Zammarchi E; Morrone A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):160-4. PubMed ID: 18571950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.
    Fantur K; Hofer D; Schitter G; Steiner AJ; Pabst BM; Wrodnigg TM; Stütz AE; Paschke E
    Mol Genet Metab; 2010 Jul; 100(3):262-8. PubMed ID: 20409738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G
    Schalli M; Tysoe C; Fischer R; Pabst BM; Thonhofer M; Paschke E; Rappitsch T; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Carbohydr Res; 2017 Apr; 443-444():15-22. PubMed ID: 28319682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis.
    Tessitore A; del P Martin M; Sano R; Ma Y; Mann L; Ingrassia A; Laywell ED; Steindler DA; Hendershot LM; d'Azzo A
    Mol Cell; 2004 Sep; 15(5):753-66. PubMed ID: 15350219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of the normal canine beta-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis.
    Wang ZH; Zeng B; Shibuya H; Johnson GS; Alroy J; Pastores GM; Raghavan S; Kolodny EH
    J Inherit Metab Dis; 2000 Sep; 23(6):593-606. PubMed ID: 11032334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-galactosidase deficiency in a Korat cat: a new form of feline GM1-gangliosidosis.
    De Maria R; Divari S; Bo S; Sonnio S; Lotti D; Capucchio MT; Castagnaro M
    Acta Neuropathol; 1998 Sep; 96(3):307-14. PubMed ID: 9754965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.
    Rigat BA; Tropak MB; Buttner J; Crushell E; Benedict D; Callahan JW; Martin DR; Mahuran DJ
    Mol Genet Metab; 2012 Sep; 107(1-2):203-12. PubMed ID: 22784478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Arg482His mutation in the beta-galactosidase gene is responsible for a high frequency of GM1 gangliosidosis carriers in a Cypriot village.
    Georgiou T; Stylianidou G; Anastasiadou V; Caciotti A; Campos Y; Zammarchi E; Morrone A; D'azzo A; Drousiotou A
    Genet Test; 2005; 9(2):126-32. PubMed ID: 15943552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.